Intra-individual Comparison of Conventional and Digital PET/CT Scanners

Intra-individual Patient-based Comparison of Conventional and Digital PET/CT Scanners

In this study, the investigators will analyze the impact of digital PET/CT on the final diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal cancer and a group of mescellaneous cancers.

There will be a single injection of the PET radiopharmaceutical FDG, followed by a conventional PET/CT scan and a digital PET scan, in this order or vice versa.

Inclusion criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

• referred to Isala for a clinically indicated FDG-PET/CT scan
• suspected or proven lung cancer, esophageal cancer, breast cancer or miscellaneous cancer, either as a primary diagnosis or follow-up study
• signed informed consent

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

• age < 18 years
• incapacitated adults
• prisoners
• pregnant patients
• unable to undergo two consecutive PET/CT scans